Virtu Financial LLC Lexicon Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$1.3 - $3.58 $56,668 - $156,055	43,591 New	43,591 $105,000
Q2 2023 Jul 27, 2023	SELL	$2.15 - $3.49 $3,829 - $6,215	-1,781 Reduced 8.2%	19,948 $46,000
Q1 2023 May 01, 2023	BUY	$1.99 - $2.68 $43,240 - $58,233	21,729 New	21,729 $53,000
Q3 2022 Nov 07, 2022	BUY	$1.94 - $3.43 $26,108 - $46,160	13,458 New	13,458 $32,000
Q3 2020 Dec 11, 2020	SELL	$1.44 - $2.1 $99,766 - $145,492	-69,282 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$1.75 - $2.3 $121,243 - $159,348	69,282 New	69,282 $138,000
Q2 2019 Aug 13, 2019	SELL	$5.35 - $7.11 $188,127 - $250,016	-35,164 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$4.36 - $7.94 $153,315 - $279,202	35,164 New	35,164 $196,000
Q4 2017 Feb 09, 2018	SELL	$8.77 - $12.28 $105,178 - $147,274	-11,993 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$12.17 - $16.3 $145,954 - $195,485	11,993	11,993 $0

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $143M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.